# CYTOAGENTS, INC.: CTO1681 to prevent and mitigate cytokine release syndrome in multiple myeloma patients receiving CAR T-cell therapy

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | CYTOAGENTS, INC. |
| Location | PITTSBURGH, PA |
| Project | CTO1681 to prevent and mitigate cytokine release syndrome in multiple myeloma patients receiving CAR T-cell therapy |
| Project number | 5R44CA295189-02 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $936,370 |
| Awarded | 2026-09-17 |
| Project period | 2025-09-22 to 2027-08-31 |
| UEI | CCEZCKNKL9M4 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11418976). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.